首页|润目逍遥散对干眼肝经郁热证模型小鼠角膜、泪腺组织miR-146a-5p与IRAK1/TRAF6/NF-κB信号通路的影响

润目逍遥散对干眼肝经郁热证模型小鼠角膜、泪腺组织miR-146a-5p与IRAK1/TRAF6/NF-κB信号通路的影响

扫码查看
目的 从miR-146a-5p与白细胞介素1受体相关激酶1/肿瘤坏死因子受体相关因子6/核因子κB(IRAK1/TRAF6/NF-KB)信号通路探讨润目逍遥散治疗干眼肝经郁热证的可能机制.方法 80只C57BL/6J小鼠随机分为正常组、模型组、激动剂组、抑制剂组、玻璃酸钠组和润目逍遥散高、中、低剂量组,每组10只.除正常组外,其余各组小鼠采用苯扎氯铵溶液滴眼联合慢性疼痛刺激构建干眼肝经郁热证小鼠模型.于造模第30日开始,润目逍遥散高、中、低剂量组小鼠分别给予润目逍遥散每次29、14.5、7.25g/kg,每日2次灌胃;玻璃酸钠组小鼠双眼给予玻璃酸钠滴眼液每次每只眼5 µ1,每日2次;激动剂组小鼠双眼每次每只眼给予agomir-146a-5p 2 nmol滴眼,抑制剂组小鼠双眼给予antagomir-146a-5p 5 nmol滴眼,隔日1次,每周3次;正常组、模型组小鼠按1ml/(100g·d)灌胃去离子水.各组均持续干预14天,最后一次干预后次日检测各组小鼠泪液分泌量、泪膜破裂时间、角膜荧光素染色情况、易激惹程度评分;HE染色观察各组小鼠角膜、泪腺的病理情况;检测角膜、泪腺炎症因子白细胞介素1β(IL-1β)、肿瘤坏死因子a(TNF-a)、miR-146a-5p表达;检测角膜中基质金属蛋白酶3(MMP-3)、基质金属蛋白酶9(MMP-9)表达,角膜、泪腺中IRAK1、TRAF6、核因子 κB p65(NF-κB p65)蛋白及mRNA表达,磷酸化核因子 κBp65(p-NF-κB p65)蛋白表达.结果 与正常组比较,模型组小鼠泪液分泌量减少、泪膜破裂时间缩短、易激惹程度评分增高(P<0.05),病理显示角膜中央出现染色、有明显角膜损伤,泪腺腺泡细胞体积增大,排列紊乱,大量炎性细胞浸润,新生血管增多的表现;角膜、泪腺组织中IL-1β、TNF-a表达升高,miR-146a-5p表达降低,IRAK1、TRAF6、NF-κB p65、p-NF-κB p65 蛋白与 IRAK1、TRAF6、NF-κB p65 mRNA表达升高,角膜中 MMP-3、MMP-9蛋白表达升高(P<0.05).与模型组比较,润目逍遥散高剂量组上述各指标均显著改善,而玻璃酸钠组和润目逍遥散中、低剂量组部分指标改善(P<0.05).与模型组比较,激动剂组角膜、泪腺IRAK1、TRAF6 mRNA及IRAK1、TRAF6、p-NF-κB p65蛋白表达降低;与抑制剂组相比,润目逍遥散各剂量组角膜、泪腺中部分IRAK1、TRAF6、NF-κB p65 mRNA及蛋白表达下降(P<0.05).结论 润目逍遥散可以通过上调miR-146a-5p负调控肝经郁热证干眼模型小鼠角膜及泪腺中IRAK1/TRAF6/NF-κB信号通路,从而抑制炎症反应减轻眼表组织损伤,且以高剂量效果最好.
Effects of Runmu Xiaoyao Powder(润目逍遥散)for Dry Eyes Mice with Liver-Meridian Constraint-Heat Syndrome on miR-146a-5p and IRAK 1/TRAF6/NF-κB Signalling Pathway in Cornea and Lacrimal Gland Tissue
Objective To explore the possible mechanism of the treatment of dry eye with liver-meridian constraint-heat syndrome by Runmu Xiaoyao Powder(润目逍遥散)by miR-146a-5pand interleukin-1 receptor-associated kinase 1/tumour necrosis factor receptor associated factor 6/nuclear factor-κB(IRAK1/TRAF6/NF-κB)signalling pathway.Methods Eighty C57BL/6J mice were randomly divided into normal group,model group,agonist group,inhibitor group,sodium hyaluronate group,and Runmu Xiaoyao Powder high-,medium-,and low-dose groups,with 10 mice in each group.Except for the normal group,the mice of dry eye with liver-meridian constraint-heat syndrome were modeled by using benzalkonium chloride solution eye drops combined with chronic pain stimulation.Beginning on the 30th day of modelling,mice in Runmu Xiaoyao Powder high-,medium-,and low-dose groups were given 29,14.5,and 7.25 g/kg of Runmu Xiaoyao Powder respectively twice daily by gavage;mice in sodium hyaluronate group were given 5 pl of sodium hyaluronate drops twice daily;mice in the agonist group were given 2 nmol of agomir-146a-5p drops in each eye at a time,and those in the inhibitor group were given 5 nmol of antagomir-146a-5p drops in each eye,with every other day,3 times per week;mice in the normal and model groups were gavaged with deionised water at 1 ml/(100 g·d).The intervention was continued for 14 days in each group,and mice in each group were examined for tear secretion,tear film rupture time,corneal fluorescein staining,and irritability scores on the day following the last intervention;HE staining was used to observe the pathological conditions of the cornea and lacrimal glands in each group;corneal and lacrimal gland inflammatory factors,such as interleukin 1 β(IL-1β),tumour necrosis factorα(TNF-α),miR-146a-5p expression,were examined;matrix metalloproteinase 3(MMP-3)and matrix metallopro-teinase 9(MMP-9)expression in cornea,IRAK1,TRAF6,nuclear factor κB p65(NF-κB p65)protein and mRNA expression in cornea and lacrimal gland,and phosphorylated nuclear factor κB p65(p-NF-κB p65)protein expres-sion were detected.Results Compared with the normal group,mice in the model group showed reduced tear secre-tion,shorter tear film rupture time,higher irritability score(P<0.05),and pathological examination showed stain-ing in the centre of the cornea,obvious corneal damage,increased volume of lacrimal gland follicular cells,disor-dered arrangement,a large number of inflammatory cell infiltration,and increased neovascularisation;corneal and lacrimal gland tissues showed elevated expression of IL-1 β and TNF-α,decreased expression of miR-146a-5p,ele-vated expression of IRAK1,TRAF6,NF-κB p65,p-NF-κB p65 protein and IRAK1,TRAF6,NF-κB p65 mRNA,and elevated expression of MMP-3,MMP-9 protein in the cornea(P<0.05).Compared with the model group,all of the above indexes were significantly improved in high-dose group of Runmu Xiaoyao Powder,while some indexes were improved in the sodium hyaluronate group and the middle-and low-dose Runmu Xiaoyao Powder groups(P<0.05).Compared with the model group,corneal and lacrimal IRAK1 and TRAF6 mRNA and IRAK1,TRAF6 and p-NF-κB p65 protein expression decreased in the agonist group;compared with the inhibitor group,IRAK1,TRAF6,NF-κB p65 mRNA and protein expression in the cornea and lacrimal gland in the Runmu Xiaoyao Powder groups decreased(P<0.05).Conclusion Runmu Xiaoyao Powder can negatively regulate the IRAK1/TRAF6/NF-κB signalling pathway in the cornea and lacrimal gland of mice with dry eye of liver-meridian constraint-heat syndrome by up-regulation of miR-146a-5p,so as to inhibit inflammatory response and reduce the damage of the ocular surface tissues,and the high doses group showed the best effect.

dry eyesliver-meridian constraint-heat syndromeRunmu Xiaoyao Powder(润目逍遥散)cornealacrimal gland tissueinflammatory response

刘婷婷、陈彦坤、刘培、蒋鹏飞、谭亢、颜春薇、彭清华

展开 >

湖南中医药大学,湖南省长沙市岳麓区含浦科教园学士路300号,410208

湖南中医药大学第一附属医院

干眼 肝经郁热证 润目逍遥散 角膜 泪腺组织 炎症反应

国家中医药管理局中医眼科学重点学科建设项目"刘良院士工作站"指导项目湖南省研究生科研创新项目

ZK1801YK01521YS002CX20210679

2024

中医杂志
中华中医药学会 中国中医科学院

中医杂志

CSTPCD北大核心
影响因子:1.464
ISSN:1001-1668
年,卷(期):2024.65(18)